This study provides valuable findings on the role of site-specific DNA methylation changes during spermatogenesis and their contribution to paternal epigenetic inheritance. The study proposes that ...

Our illumina HiSeq 2500 platform supports a variety of different experiments, including whole-genome and candidate-region sequencing, transcriptome analysis, small RNA discovery, methylation profiling ...

Library pools are sequenced on a single lane of an Illumina HiSeq 2500 in Rapid Run mode (Fred Hutch Genomics and Bioinformatics shared resource). Analysis was performed as described in Hsieh et al., ...

Exome-enriched libraries were sequenced on the Illumina HiSeq 2500 sequencing platform using 2×100 bp paired-end read cycles. Briefly, the variants were called following the Genome Analysis Toolkit ...

Each library was identified by adding a 6-bp adaptor and sequenced at 50-bp read by an Illumina HiSeq 2,500 Sequencer. After alignment of sequencing reads and the generation of counting matrix by ...

Samples were prepared according to Illumina’s RNA sequencing protocol and manufacturer’s instructions. The 42 cDNA libraries were divided into two groups of 24 and proceeded with two Rapid mode ...

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train ...

Illumina (ILMN) and Tempus AI (TEM) announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation. The collaboration will combine ...

The base and pessimistic DCF models implemented in this article suggest that Illumina is undervalued. Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. The DNA ...

Piper Sandler analyst David Westenberg maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $190.00. The company’s shares closed last Friday at $74.78.